Changing paradigms for an HIV vaccine.
Schultz
A M
AM
Vaccine and Prevention Research Program, Division of AIDS, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland 20852, USA.
D016915:AIDS Vaccines / Q000009:adverse effects; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control / Q000635:transmission; D000818:Animals; D015195:Drug Design; D005260:Female; D006678:HIV / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009092:Mucous Membrane / Q000276:immunology; D011323:Primates; D012725:Sexual Behavior; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology; D015302:Simian Immunodeficiency Virus
D016915:AIDS Vaccines